Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis

Article Figures & Tables

Download figure
Open in new tab
Download powerpoint
Figure 1:
Flow chart showing study participants included in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, and participants who tested positive for SARS-CoV-2 infection and were followed for clinical reassessment posttesting (day 1 and day 14).

Table 1:

Characteristics and initial symptoms of shelter residents who underwent SARS-CoV-2 testing on Apr. 20, 2020

Note: SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, SD = standard deviation.

Table 2:

Clinical symptoms of shelter residents who tested positive for SARS-CoV-2 on Apr. 20, 2020 (n = 24)^*

Clinical symptom	No. (%) of residents
Clinical symptom	On day 1 posttesting	Any time during 14 days posttesting	On day 14 posttesting
Asymptomatic	7 (29.2)	3 (12.5)	15 (62.5)
Any symptoms	17 (70.8)	21 (87.5)	9 (37.5)
Fever	7 (29.2)	8 (33.3)	0
Cough	6 (25.0)	5 (20.8)	4 (16.7)
Shortness of breath	0	1 (4.2)	0
Chills	2 (8.3)	3 (12.5)	0
Myalgias	6 (25.0)	6 (25.0)	2 (8.3)
Headache	8 (33.3)	14 (58.3)	0
Sore throat	6 (25.0)	6 (25.0)	0
New loss of taste	1 (4.2)	10 (41.7)	3 (12.5)
New loss of smell	1 (4.2)	7 (29.2)	1 (4.2)
New nasal congestion	1 (4.2)	6 (25.0)	1 (4.2)
Diarrhea	1 (4.2)	3 (12.5)	0
Malaise	3 (12.5)	5 (20.8)	1 (4.2)
Dizziness	1 (4.2)	4 (16.7)	1 (4.2)
Nausea and/or vomiting	0	2 (8.3)	1 (4.2)
Chest pain/tightness	1 (4.2)	4 (16.7)	0
Other	3 (12.5)	7 (29.2)	2 (8.3)

Note: SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
↵* One individual of the 25 who tested positive could not be contacted after initial testing.